Spinal devices maker Benvenue Medical closed a $3.5 million funding round with the help of 9 unnamed investors, according a regulatory filing.
The Santa Clara, Calif.-based company raised the funds through sales of debt, rights and securities or rights to acquire securities. Benvenue provided few other details on the funding round.
The privately held spinal devices maker, launched in 2004, designs and manufactures minimally invasive spinal repair devices. Its flagship Kiva VCF system is an "implant-based approach to vertebral augmentation in the treatment of painful [vertebral compression fractures]."
Benvenue announced last month that its Kiva system was reportedly non-inferior to balloon kyphoplasty in managing pain associated with osteolytic vertebral body metastases, while resulting eliminating incidents of cement leakage.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.